D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
NBP holding history
NovaBridge Biosciences in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NBP overviewAll 13F holders of NBPFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −17,266−100.0% | Sold out | Holders |
| Q1 2023 | 17,266 | $59.7K | <0.1% | −80,254−82.3% | Reduced | Holders |
| Q4 2022 | 97,520 | $407.6K | <0.1% | +6,325+6.9% | Added | Holders |
| Q3 2022 | 91,195 | $366.0K | <0.1% | +22,095+32.0% | Added | Holders |
| Q2 2022 | 69,100 | $781.0K | <0.1% | −13,099−15.9% | Reduced | Holders |
| Q1 2022 | 82,199 | $1.33M | <0.1% | +16,914+25.9% | Added | Holders |
| Q4 2021 | 65,285 | $3.09M | <0.1% | −155,996−70.5% | Reduced | Holders |
| Q3 2021 | 221,281 | $16.0M | <0.1% | +62,823+39.6% | Added | Holders |
| Q2 2021 | 158,458 | $13.3M | <0.1% | +120,642+319.0% | Added | Holders |
| Q1 2021 | 37,816 | $1.83M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.